MA37940A2 - Nouveaux dérivés bicycliques - Google Patents

Nouveaux dérivés bicycliques

Info

Publication number
MA37940A2
MA37940A2 MA37940A MA37940A MA37940A2 MA 37940 A2 MA37940 A2 MA 37940A2 MA 37940 A MA37940 A MA 37940A MA 37940 A MA37940 A MA 37940A MA 37940 A2 MA37940 A2 MA 37940A2
Authority
MA
Morocco
Prior art keywords
bicyclic derivatives
new bicyclic
new
derivatives
relates
Prior art date
Application number
MA37940A
Other languages
English (en)
Other versions
MA37940B1 (fr
Inventor
Daniel Hunziker
Patrizio Mattei
Harald Mauser
Jérôme Hert
Guozhi Tang
Lisha Wang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA37940A2 publication Critical patent/MA37940A2/fr
Publication of MA37940B1 publication Critical patent/MA37940B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

L'invention concerne de nouveaux composés ayant la formule générale (i) où r
MA37940A 2012-09-25 2013-09-23 Derives d'octahydro-cyclopenta(c)pyrrole substitues inhibiteurs de l'autotaxine, utiles pour traiter les affections renales, hepatiques et inflammatoires, les affections du systeme nerveux, les maladies fibreuses. MA37940B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12185941 2012-09-25
PCT/EP2013/069679 WO2014048865A1 (fr) 2012-09-25 2013-09-23 Nouveaux dérivés bicycliques

Publications (2)

Publication Number Publication Date
MA37940A2 true MA37940A2 (fr) 2016-06-30
MA37940B1 MA37940B1 (fr) 2018-09-28

Family

ID=47073290

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37940A MA37940B1 (fr) 2012-09-25 2013-09-23 Derives d'octahydro-cyclopenta(c)pyrrole substitues inhibiteurs de l'autotaxine, utiles pour traiter les affections renales, hepatiques et inflammatoires, les affections du systeme nerveux, les maladies fibreuses.

Country Status (33)

Country Link
US (4) US20150353559A1 (fr)
EP (2) EP2900669B1 (fr)
JP (1) JP6285444B2 (fr)
KR (1) KR102179599B1 (fr)
CN (1) CN104684915B (fr)
AR (1) AR092645A1 (fr)
AU (1) AU2013322838B2 (fr)
BR (1) BR112015004111A2 (fr)
CA (1) CA2878442A1 (fr)
CL (1) CL2015000706A1 (fr)
CR (1) CR20150120A (fr)
DK (1) DK2900669T3 (fr)
EA (1) EA036630B1 (fr)
ES (1) ES2753163T3 (fr)
HK (1) HK1206722A1 (fr)
HR (1) HRP20191937T1 (fr)
HU (1) HUE045797T2 (fr)
IL (1) IL237126A (fr)
IN (1) IN2015DN00960A (fr)
LT (1) LT2900669T (fr)
MA (1) MA37940B1 (fr)
MX (1) MX368615B (fr)
PE (1) PE20150758A1 (fr)
PH (1) PH12015500263A1 (fr)
PL (1) PL2900669T3 (fr)
PT (1) PT2900669T (fr)
RS (1) RS59512B1 (fr)
SG (1) SG11201500572YA (fr)
SI (1) SI2900669T1 (fr)
TW (1) TWI609018B (fr)
UA (1) UA116547C2 (fr)
WO (1) WO2014048865A1 (fr)
ZA (1) ZA201500345B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2872213A1 (fr) 2012-06-13 2013-12-19 F. Hoffmann-La Roche Ag Nouveaux composes diazaspirocycloalcane et azaspirocycloalcane
AR092645A1 (es) 2012-09-25 2015-04-29 Hoffmann La Roche Derivados biciclicos inhibidores de autotaxina (atx)
JP6363616B2 (ja) 2012-12-19 2018-07-25 ノバルティス アーゲー オートタキシン阻害剤
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
AR095079A1 (es) * 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
CA2917050A1 (fr) * 2013-07-03 2015-01-08 Todd K. Jones Composes de pyrrolo-pyrrole carbamate et composes organiques associes, compositions pharmaceutiques et leurs utilisations medicales
US9540324B2 (en) 2013-09-26 2017-01-10 Luc Therapeutics, Inc. Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
EP3878848A1 (fr) 2013-11-22 2021-09-15 Sabre Therapeutics LLC Composés d'indole inhibant l'autotaxine
UA118201C2 (uk) * 2013-11-26 2018-12-10 Ф. Хоффманн-Ля Рош Аг НОВИЙ ОКТАГІДРОЦИКЛОБУТА[1,2-c;3,4-c']ДИПІРОЛ-2-ІЛ
EP3122750B1 (fr) * 2014-03-26 2019-09-04 F.Hoffmann-La Roche Ag Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa)
MX2016010675A (es) 2014-03-26 2016-11-10 Hoffmann La Roche Compuestos condensados de [1,4]diazepina como inhibidores de produccion de la autotaxina (atx) y acido lisofosfatidico (lpa).
US9051320B1 (en) 2014-08-18 2015-06-09 Pharmakea, Inc. Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
JO3579B1 (ar) 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
GB201501870D0 (en) 2015-02-04 2015-03-18 Cancer Rec Tech Ltd Autotaxin inhibitors
GB201502020D0 (en) 2015-02-06 2015-03-25 Cancer Rec Tech Ltd Autotaxin inhibitory compounds
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
JP6873919B2 (ja) 2015-05-27 2021-05-19 セイバー セラピューティクス エルエルシー オートタキシン阻害剤とその使用
US10118904B2 (en) 2015-06-05 2018-11-06 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of Demyelinating Diseases
MX2020004504A (es) 2015-09-04 2021-11-10 Hoffmann La Roche Derivados de fenoximetilo.
EP3353181B1 (fr) * 2015-09-24 2021-08-11 F. Hoffmann-La Roche AG Composes bicycliques utiles comme inhibiteurs atx
RU2018114289A (ru) * 2015-09-24 2019-10-24 Ф. Хоффманн-Ля Рош Аг Бициклические соединения в качестве ингибиторов аутотаксина (atx)
MX2018001890A (es) 2015-09-24 2018-06-20 Hoffmann La Roche Compuestos biciclicos como inhibidores de autotaxina (atx).
BR112018006080A2 (pt) * 2015-09-24 2018-10-09 F. Hoffmann-La Roche Ag novos compostos bicíclicos como inibidores de dupla ação de atx/ca
CN106986789B (zh) * 2016-01-20 2019-07-16 中国人民解放军军事医学科学院生物医学分析中心 对苯二酚类化合物及其制备方法与在抗肿瘤或免疫调节中的应用
WO2017197192A1 (fr) 2016-05-12 2017-11-16 Abide Therapeutics, Inc. Composés spirocycliques et procédés de préparation et d'utilisation de ceux-ci
JOP20190107A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
WO2018106641A1 (fr) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Pyrazoles pour le traitement de maladies démyélinisantes
WO2018106643A1 (fr) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Azoles hétérocycliques pour le traitement de maladies de démyélinisation
WO2018106646A1 (fr) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Aminotriazoles pour traiter des maladies démyélinisantes
WO2018114677A2 (fr) 2016-12-19 2018-06-28 Bayer Pharma Aktiengesellschaft [(phénylsulfonyl)octahydro-épiminoisoindol-yl](1h-1,2,3-triazol-5-yl)méthanones
EP3596060B1 (fr) 2017-03-16 2023-09-20 F. Hoffmann-La Roche AG Nouveaux composés bicycliques utilisés en tant qu'inhibiteurs d'atx
CR20190423A (es) 2017-03-16 2019-11-01 Hoffmann La Roche Nuevos compuestos biciclícos como inhibidores dobles de atx/ca
DK3483164T3 (da) 2017-03-20 2020-03-23 Forma Therapeutics Inc Pyrrolopyrrolsammensætninger som pyruvatkinase (pkr) aktivatorer
MX2020002254A (es) 2017-08-29 2020-07-20 Lundbeck La Jolla Research Center Inc Compuestos espirociclicos y sus metodos de preparacion y uso.
BR112020004101A2 (pt) 2017-08-29 2020-09-24 Lundbeck La Jolla Research Center, Inc. compostos de espirociclo e métodos para produzir e usar os mesmos
WO2019076358A1 (fr) 2017-10-19 2019-04-25 Js Innopharm (Shanghai) Ltd Composés hétérocycliques, compositions comprenant le composé hétérocyclique, et leurs procédés d'utilisation
TWI780281B (zh) * 2017-12-14 2022-10-11 丹麥商Nmd藥品公司 用於治療神經肌肉病症的化合物
WO2020061255A1 (fr) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activation de la pyruvate kinase r
WO2020061378A1 (fr) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Traitement de la drépanocytose avec un composé activant la pyruvate kinase r
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
CN113549063B (zh) * 2020-04-23 2024-04-05 南京药石科技股份有限公司 一种光学异构的八氢-2H-吡咯并[3,4-c]吡啶-2-羧酸叔丁酯的制备方法
WO2022003557A1 (fr) * 2020-06-30 2022-01-06 Cadila Healthcare Limited Nouveaux inhibiteurs de l'autotaxine
TW202229255A (zh) 2020-11-13 2022-08-01 丹麥商H 朗德貝克公司 Magl抑制劑
CN113214111A (zh) * 2021-04-30 2021-08-06 上海立科化学科技有限公司 3-(2-氰基苯基)丙酸及4-氰基-1-茚满酮的制备方法

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1252898B (de) 1965-06-12 1967-10-26 Bayer Ag Verfahren zur Herstellung von Copolymerisaten des Trioxans
US5240928A (en) 1989-07-03 1993-08-31 Merck & Co., Inc. Substituted quinazolinones as angiotensin II antagonists
DE3930262A1 (de) 1989-09-11 1991-03-21 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA2037630C (fr) 1990-03-07 2001-07-03 Akira Morimoto Composes heterocycliques renfermant de l'azote, methode de production et applications correspondantes
US5470975A (en) 1990-10-16 1995-11-28 E.R. Squibb & Sons, Inc. Dihydropyrimidine derivatives
US5290780A (en) 1991-01-30 1994-03-01 American Cyanamid Co. Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US5238942A (en) 1991-05-10 1993-08-24 Merck & Co., Inc. Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
US5202322A (en) 1991-09-25 1993-04-13 Merck & Co., Inc. Quinazolinone and pyridopyrimidine a-II antagonists
US5532243A (en) 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
US5358951A (en) 1993-04-23 1994-10-25 American Cyanamid Company Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
DE4407047A1 (de) * 1994-03-03 1995-09-07 Merck Patent Gmbh Acetamide
US20010016657A1 (en) * 1997-03-18 2001-08-23 Smithkline Beecham P.L.C. Substituted isoquinoline derivatives and their use as anticonvulsants
YU41100A (sh) 1998-02-04 2002-06-19 Banyu Pharmaceutical Co. Ltd. N-acil derivati cikličnih amina
JP2001039950A (ja) 1999-07-30 2001-02-13 Banyu Pharmaceut Co Ltd N−アシル環状アミン誘導体
ATE250604T1 (de) 1999-10-27 2003-10-15 Millennium Pharm Inc Pyridyl enthaltende spirocyclische verbindungen als inhibitoren der fibrinogen-abhängigen blutplättchen aggregation
US7034024B1 (en) * 1999-11-09 2006-04-25 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment
CA2440803A1 (fr) 2001-03-07 2002-09-12 Pfizer Products Inc. Modulateurs de l'activite du recepteur de la chimiokine
WO2003086288A2 (fr) 2002-04-12 2003-10-23 Merck & Co., Inc. Amides bicycliques
GB0303852D0 (en) 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
WO2005023762A1 (fr) 2003-09-04 2005-03-17 Abbott Laboratories Derives de pyrrolidine-2-carbonitrile et leur utilisation comme inhibiteurs de la dipeptidyle peptidase-iv (dpp-iv)
SE0302811D0 (sv) 2003-10-23 2003-10-23 Astrazeneca Ab Novel compounds
GB0324790D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
US7226951B2 (en) 2003-12-17 2007-06-05 Allergan, Inc. Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
AU2005219438B2 (en) 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US7435831B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
PL1761542T3 (pl) * 2004-06-09 2008-06-30 Hoffmann La Roche Pochodne oktahydropirolo[3,4-c]pirolu i ich zastosowanie jako środków przeciwwirusowych
US7923554B2 (en) 2004-08-10 2011-04-12 Janssen Pharmaceutica N.V. HIV inhibiting 1,2,4-triazin-6-one derivatives
US7410949B2 (en) 2005-01-18 2008-08-12 Hoffmann-La Roche Inc. Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
BRPI0610433A2 (pt) 2005-04-28 2010-11-23 Wyeth Corp forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada
US7737279B2 (en) 2005-05-10 2010-06-15 Bristol-Myers Squibb Company 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
TW200800999A (en) 2005-09-06 2008-01-01 Astrazeneca Ab Novel compounds
PT1942108E (pt) 2005-10-28 2013-10-24 Ono Pharmaceutical Co Composto com um grupo básico e a sua utilização
EP3112349A3 (fr) * 2005-11-14 2017-03-01 Purdue Research Foundation Procédé de préparation de indenoisoquinolines n substitués
EP1961744B1 (fr) 2005-11-18 2013-04-17 Ono Pharmaceutical Co., Ltd. Composé contenant un groupe basique et son utilisation
WO2007103719A2 (fr) 2006-03-03 2007-09-13 Incyte Corporation MODULATEURS DE LA 11-β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
JP2008031064A (ja) 2006-07-27 2008-02-14 Astellas Pharma Inc ジアシルピペラジン誘導体
US7820649B2 (en) 2006-09-11 2010-10-26 N.V. Organon Quinazolinone and isoquinolinone acetamide derivatives
CA2663500A1 (fr) 2006-09-15 2008-03-20 Schering Corporation Derives d'azetidine spiro-condenses convenant pour le traitement de la douleur, du diabete et des troubles du metabolisme des lipides
US8735411B2 (en) 2006-10-02 2014-05-27 Abbvie Inc. Macrocyclic benzofused pyrimidine derivatives
CA2669884A1 (fr) 2006-11-15 2008-05-22 High Point Pharmaceuticals, Llc Nouveaux 2-(2-hydroxyphenyl)benzimidazoles utilises pour traiter l'obesite et le diabete
TW200831085A (en) 2006-12-13 2008-08-01 Merck & Co Inc Non-nucleoside reverse transcriptase inhibitors
EP1975165A1 (fr) 2007-03-27 2008-10-01 Boehringer Ingelheim Pharma GmbH & Co. KG Pyrrolidinamide substituée, sa fabrication et son utilisation en tant que médicament
CN101657433A (zh) 2007-03-29 2010-02-24 弗·哈夫曼-拉罗切有限公司 非核苷逆转录酶抑制剂
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
AU2008248996A1 (en) 2007-04-27 2008-11-13 Sanofi-Aventis 2 -heteroaryl- pyrrolo [3, 4-C] pyrrole derivatives and their use as SCD inhibitors
DE102007047737A1 (de) 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidin- und Piperazinderivate
MX2010004281A (es) 2007-10-19 2010-09-10 Sarcode Corp Composiciones y metodos para el tratamiento de la retinopatia diabetica.
UY31443A1 (es) 2007-10-31 2009-04-30 Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
JP2009161449A (ja) 2007-12-28 2009-07-23 Lion Corp Ppar活性促進剤並びに美容用飲食品、皮膚外用剤及び医薬
CA2727914A1 (fr) 2008-06-19 2009-12-23 Banyu Pharmaceutical Co., Ltd. Derive de spirodiamine-diarylcetoxime
EP2328898B1 (fr) 2008-09-09 2014-12-24 Sanofi Dérivés 2-hétéroaryl-pyrrolo[3,4-c]pyrrole et leur utilisation comme inhibiteurs de scd
TW201020247A (en) 2008-11-06 2010-06-01 Gruenenthal Gmbh Substituierte disulfonamide
WO2010055006A1 (fr) 2008-11-17 2010-05-20 F. Hoffmann-La Roche Ag Acides naphtylacétiques employés en tant qu'antagonistes ou agonistes partiels de crth2
DE102008059578A1 (de) 2008-11-28 2010-06-10 Merck Patent Gmbh Benzo-Naphtyridin Verbindungen
KR20110093923A (ko) 2008-12-01 2011-08-18 메르크 파텐트 게엠베하 암에 대한 오토탁신 저해제로서의 2,5-디아미노-치환된 피리도 [4,3-d]피리미딘
TW201035102A (en) 2009-03-04 2010-10-01 Gruenethal Gmbh Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
TW201038572A (en) 2009-03-25 2010-11-01 Gruenenthal Gmbh Substituted spiro-amide compounds
EP2414330B1 (fr) 2009-04-02 2013-05-01 Merck Patent GmbH Dérivés de pipéridine et de pyrazine comme inhibiteurs de l'autotaxine
WO2010112124A1 (fr) * 2009-04-02 2010-10-07 Merck Patent Gmbh Inhibiteurs de l'autotaxine
CA2757413C (fr) 2009-04-02 2017-01-10 Merck Patent Gmbh Composes heterocycliques comme inhibiteurs de l'autotaxine
FR2945534B1 (fr) 2009-05-12 2012-11-16 Sanofi Aventis DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US8648066B2 (en) 2009-05-22 2014-02-11 Exelixis, Inc. Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
US20120083476A1 (en) 2009-06-05 2012-04-05 Janssen Pharmaceutica Nv Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
DE102009033392A1 (de) * 2009-07-16 2011-01-20 Merck Patent Gmbh Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
JP2013501064A (ja) 2009-08-04 2013-01-10 アミラ ファーマシューティカルス,インコーポレーテッド リゾホスファチジン酸受容体アンタゴニストとしての化合物
UA107360C2 (en) 2009-08-05 2014-12-25 Biogen Idec Inc Bicyclic aryl sphingosine 1-phosphate analogs
AR079022A1 (es) 2009-11-02 2011-12-21 Sanofi Aventis Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
AU2011204323B2 (en) * 2010-01-07 2013-12-12 E. I. Du Pont De Nemours And Company Fungicidal heterocyclic compounds
US8815869B2 (en) 2010-03-18 2014-08-26 Abbvie Inc. Lactam acetamides as calcium channel blockers
PL2547679T3 (pl) 2010-03-19 2016-02-29 Pfizer Pochodne 2,3-dihydro-1H-inden-1-ylo-2,7-diazaspiro[3.5]nonanu i ich zastosowanie jako antagonistów lub odwrotnych agonistów receptora greliny
EP2552914B1 (fr) 2010-03-26 2015-11-11 Merck Patent GmbH Benzonaphthyridinamines en tant qu'inhibiteurs d'autotaxine
GB201008005D0 (en) 2010-05-13 2010-06-30 Sentinel Oncology Ltd Pharmaceutical compounds
EP2575794A2 (fr) 2010-06-04 2013-04-10 B.S.R.C. "Alexander Fleming" Modulation de la voie autotaxine et utilisations correspondantes
AR082590A1 (es) 2010-08-12 2012-12-19 Hoffmann La Roche Inhibidores de la tirosina-quinasa de bruton
JP2013536200A (ja) * 2010-08-20 2013-09-19 アミラ ファーマシューティカルス,インコーポレーテッド オートタキシン阻害剤およびその使用
EP2611808B1 (fr) * 2010-09-02 2014-11-12 Merck Patent GmbH Dérivés de pyrazolopyridinone en tant qu'antagonistes de récepteur de lpa
US20140031547A1 (en) 2010-12-14 2014-01-30 Electrophoretics Limited CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
WO2012166415A1 (fr) 2011-05-27 2012-12-06 Amira Pharmaceuticals, Inc. Inhibiteurs hétérocycliques d'autotaxine et leurs utilisations
EP2751118B1 (fr) 2011-08-29 2016-10-12 Bristol-Myers Squibb Company Dérivés spiraniques de diamine bicyclique utilisés en tant qu'inhibiteurs de la fixation du vih
WO2013054185A1 (fr) 2011-10-13 2013-04-18 Pfizer, Inc. Dérivés de pyrimidine et de pyridine utiles en thérapie
JPWO2013065712A1 (ja) 2011-10-31 2015-04-02 東レ株式会社 ジアザスピロウレア誘導体及びその医薬用途
US8809552B2 (en) 2011-11-01 2014-08-19 Hoffmann-La Roche Inc. Azetidine compounds, compositions and methods of use
EP2800745B1 (fr) 2011-12-02 2020-02-12 Phenex Pharmaceuticals AG Pyrroloarboxamides comme modulateurs de l'activité de récepteur-gamma orphelin (rory, nr1f3) associé au rar de récepteur nucléaire orphelin et pour le traitement des maladies inflammatoires et de maladies auto-immunes chroniques
TWI638802B (zh) 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚o-甲基轉移酶活性抑制化合物
CA2872213A1 (fr) 2012-06-13 2013-12-19 F. Hoffmann-La Roche Ag Nouveaux composes diazaspirocycloalcane et azaspirocycloalcane
UA117347C2 (uk) 2012-06-13 2018-07-25 Інсайт Холдинґс Корпорейшн Заміщені трициклічні сполуки як інгібітори fgfr
TWI616430B (zh) 2012-07-27 2018-03-01 百健Ma公司 Atx調節劑
MX362346B (es) 2012-07-27 2019-01-11 Biogen Ma Inc Compuestos que son agentes moduladores de s1p y/o agentes moduladores de autotaxina.
AR092645A1 (es) 2012-09-25 2015-04-29 Hoffmann La Roche Derivados biciclicos inhibidores de autotaxina (atx)
DK2900269T3 (en) 2012-09-25 2018-10-01 Bayer Pharma AG COMBINATION OF REGORAFENIB AND ACETYLSALICYLIC ACID FOR TREATMENT OF COLORECTAL CANCER.
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
BR112015009168B1 (pt) 2012-10-25 2022-09-27 Tetra Discovery Partners, LLC Composto de fórmula estrutural xi ou um sal do mesmo, uso de um composto e composição farmacêutica
US20160002247A1 (en) 2013-03-01 2016-01-07 The University Of Tokyo 8-substituted imidazopyrimidinone derivative having autotaxin inhibitory activity
TWI593692B (zh) 2013-03-12 2017-08-01 美國禮來大藥廠 四氫吡咯并噻嗪化合物
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
AU2014248878A1 (en) 2013-03-12 2015-09-24 Acucela Inc. Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
RU2015143192A (ru) 2013-03-12 2017-04-17 Эббви Инк. Тетрациклические ингибиторы бромодоменов
AR095328A1 (es) 2013-03-15 2015-10-07 Biogen Idec Inc Agentes de modulación de s1p y/o atx
US9763957B2 (en) 2013-07-18 2017-09-19 Novartis Ag Autotaxin inhibitors
TR201807411T4 (tr) 2013-10-17 2018-06-21 Vertex Pharma DNA-PK inhibitörleri.
EP3878848A1 (fr) 2013-11-22 2021-09-15 Sabre Therapeutics LLC Composés d'indole inhibant l'autotaxine
AR098475A1 (es) 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
UA118201C2 (uk) 2013-11-26 2018-12-10 Ф. Хоффманн-Ля Рош Аг НОВИЙ ОКТАГІДРОЦИКЛОБУТА[1,2-c;3,4-c']ДИПІРОЛ-2-ІЛ
WO2015144480A1 (fr) 2014-03-26 2015-10-01 Basf Se Composés d'imidazole et de [1,2,4]-triazole substitués utilisés comme fongicides
EP3122750B1 (fr) 2014-03-26 2019-09-04 F.Hoffmann-La Roche Ag Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa)
MX2016010675A (es) 2014-03-26 2016-11-10 Hoffmann La Roche Compuestos condensados de [1,4]diazepina como inhibidores de produccion de la autotaxina (atx) y acido lisofosfatidico (lpa).
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
CA2943874A1 (fr) 2014-04-04 2015-10-08 X-Rx, Inc. Inhibiteurs spirocycliques substitues d'autotaxine
UA118989C2 (uk) 2014-10-14 2019-04-10 Вітае Фармасьютікалс, Інк. Дигідропіролопіридинові інгібітори ror-гамма
BR112017017052A2 (pt) 2015-02-15 2018-04-10 F. Hoffmann-La Roche Ag derivados de 1-(het)arilsulfonil-(pirrolidina ou piperidina)-2-carboxamida e seu uso como antagonistas de trpa1
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
CN104927727B (zh) 2015-07-06 2017-01-11 香山红叶建设有限公司 一种玻璃幕墙用结构密封胶及其制备方法
MX2020004504A (es) 2015-09-04 2021-11-10 Hoffmann La Roche Derivados de fenoximetilo.
PL415078A1 (pl) 2015-09-04 2017-03-13 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
EP3353181B1 (fr) 2015-09-24 2021-08-11 F. Hoffmann-La Roche AG Composes bicycliques utiles comme inhibiteurs atx
MX2018001890A (es) 2015-09-24 2018-06-20 Hoffmann La Roche Compuestos biciclicos como inhibidores de autotaxina (atx).
BR112018006080A2 (pt) 2015-09-24 2018-10-09 F. Hoffmann-La Roche Ag novos compostos bicíclicos como inibidores de dupla ação de atx/ca
RU2018113709A (ru) 2015-09-24 2019-10-30 Айонис Фармасьютикалз, Инк. Модуляторы экспрессии kras
RU2018114289A (ru) 2015-09-24 2019-10-24 Ф. Хоффманн-Ля Рош Аг Бициклические соединения в качестве ингибиторов аутотаксина (atx)
SG11201803210YA (en) 2015-11-25 2018-05-30 Dana Farber Cancer Inst Inc Bivalent bromodomain inhibitors and uses thereof
KR102070746B1 (ko) 2015-12-01 2020-01-29 니혼노야쿠가부시키가이샤 3h-피롤로피리딘 화합물 또는 그의 n-옥사이드, 또는 그들의 염류 및 상기 화합물을 함유하는 농원예용 살충제 및 그의 사용 방법
WO2017139978A1 (fr) 2016-02-19 2017-08-24 吴伟东 Procédé et système d'actualisation d'application de téléphone mobile
CR20190423A (es) 2017-03-16 2019-11-01 Hoffmann La Roche Nuevos compuestos biciclícos como inhibidores dobles de atx/ca
EP3596060B1 (fr) 2017-03-16 2023-09-20 F. Hoffmann-La Roche AG Nouveaux composés bicycliques utilisés en tant qu'inhibiteurs d'atx
DK3483164T3 (da) 2017-03-20 2020-03-23 Forma Therapeutics Inc Pyrrolopyrrolsammensætninger som pyruvatkinase (pkr) aktivatorer

Also Published As

Publication number Publication date
US20180118741A1 (en) 2018-05-03
PE20150758A1 (es) 2015-05-15
ZA201500345B (en) 2015-12-23
TWI609018B (zh) 2017-12-21
IN2015DN00960A (fr) 2015-06-12
PH12015500263B1 (en) 2015-03-30
CR20150120A (es) 2015-04-14
CA2878442A1 (fr) 2014-04-03
US10669268B2 (en) 2020-06-02
HRP20191937T1 (hr) 2020-01-10
JP2015531360A (ja) 2015-11-02
TW201422618A (zh) 2014-06-16
JP6285444B2 (ja) 2018-02-28
SG11201500572YA (en) 2015-02-27
SI2900669T1 (sl) 2019-12-31
PH12015500263A1 (en) 2015-03-30
MX368615B (es) 2019-10-09
PL2900669T3 (pl) 2020-01-31
CN104684915A (zh) 2015-06-03
PT2900669T (pt) 2019-10-29
RS59512B1 (sr) 2019-12-31
BR112015004111A2 (pt) 2017-07-04
CL2015000706A1 (es) 2015-08-07
EP2900669A1 (fr) 2015-08-05
IL237126A (en) 2016-12-29
WO2014048865A1 (fr) 2014-04-03
AU2013322838A1 (en) 2015-01-29
AR092645A1 (es) 2015-04-29
HUE045797T2 (hu) 2020-01-28
ES2753163T3 (es) 2020-04-07
CN104684915B (zh) 2017-10-31
LT2900669T (lt) 2019-11-11
US20170050960A1 (en) 2017-02-23
AU2013322838B2 (en) 2018-02-01
EA036630B1 (ru) 2020-12-02
EA201590534A1 (ru) 2015-07-30
HK1206722A1 (en) 2016-01-15
KR102179599B1 (ko) 2020-11-19
KR20150060713A (ko) 2015-06-03
MA37940B1 (fr) 2018-09-28
EP3590940A1 (fr) 2020-01-08
EP3590940B1 (fr) 2021-06-09
DK2900669T3 (da) 2019-11-04
MX2015002090A (es) 2015-05-11
US20200339570A1 (en) 2020-10-29
EP2900669B1 (fr) 2019-09-04
US20150353559A1 (en) 2015-12-10
UA116547C2 (uk) 2018-04-10

Similar Documents

Publication Publication Date Title
MA37940A2 (fr) Nouveaux dérivés bicycliques
MA35664B1 (fr) Nouveaux dérivés bicycliques de la dihydroisoquinoline-1-one
MA34389B1 (fr) Nouvelles aminopyrazoloquinazolines
MA35049B1 (fr) Triazolopyridines
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
AU2014270524A8 (en) 2-phenylimidazo [1,2-a]pyrimidines as imaging agents
MA35089B1 (fr) Inhibiteurs de la production de leucotrienes de type benzodioxane
IN2014MN02496A (fr)
MA37756A1 (fr) Nouveaux composés diazaspirocycloalcane et azaspirocycloalcane
AU2012334173A8 (en) [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
CO6831982A2 (es) Pirazolo[4,3-d]pirimidinas útiles como inhibidores de cinasas
CR20140132A (es) Derivados de pirrolopirimidina y purina
CR20140042A (es) Indazoles
CR20130470A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA
MA35086B1 (fr) Compose de triazolopyridine
UY34445A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
MA35357B1 (fr) Composes de type anilines
CR20140510A (es) Nucleósidos de espirooxetano de uracilo
CR20130369A (es) Novedosos derivados heterocíclicos
CR20120295A (es) Triazolopiridinas
EA202190619A1 (ru) Противовирусные соединения
CR20120297A (es) Espironucleósidos uracílicos oxetánicos
EA201491002A1 (ru) Производные [1,2,3]триазоло[4,5-d]пиримидина в качестве агонистов каннабиноидного рецептора 2
IN2014MN01521A (fr)
MA38645B1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes